Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123807072> ?p ?o ?g. }
- W2123807072 abstract "This is an updated version of the original Cochrane review on parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy (published in Issue 3, 2007). Salivary gland dysfunction is a predictable side effect of radiotherapy to the head and neck region. Pilocarpine hydrochloride (a choline ester) is licensed in many countries for the treatment of radiation-induced salivary gland dysfunction. Other parasympathomimetics have also been used 'off licence' in the treatment of this condition.To determine the efficacy and tolerability of parasympathomimetic drugs in the treatment of radiation-induced salivary gland dysfunction (specifically radiation-induced xerostomia).For this update, we ran searches of the Cochrane Oral Health Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 6), MEDLINE, EMBASE, and CINAHL in July 2015. We checked the reference lists of retrieved articles for additional studies, contacted experts in the field for unpublished and ongoing trials, and contacted relevant pharmaceutical companies for unpublished and ongoing trials.The selection criteria for the review were: 1) randomised controlled trials; 2) people suffering from radiation-induced salivary gland dysfunction; 3) people treated with parasympathomimetic drugs; and 4) assessable data available on primary outcome measure.The two review authors independently collected data from the full-text version of relevant papers including: 1) citation details; 2) participants; 3) interventions; 4) assessments; 5) outcomes (that is efficacy, tolerability); and 6) quality issues.Due to a lack of appropriate data, we were unable to perform a meta-analysis.In the original review, three studies, including a total of 298 participants, fulfilled the inclusion criteria. All three studies involved the use of pilocarpine hydrochloride. We have included no additional studies in the update of the review; we have excluded eight additional studies.The data suggest that pilocarpine hydrochloride is more effective than placebo and at least as effective as artificial saliva. The response rate was 42% to 51%. The time to response was up to 12 weeks. The overall side effect rate was high, and side effects were the main reason for withdrawal (6% to 15% of participants taking 5 mg three times a day had to withdraw). The side effects were usually the result of generalised parasympathomimetic stimulation (for example sweating, headaches, urinary frequency, vasodilatation). Response rates were not dose dependent, but side effect rates were dose dependent.There is limited evidence to support the use of pilocarpine hydrochloride in the treatment of radiation-induced xerostomia. Currently, there is little evidence to support the use of other parasympathomimetic drugs in the treatment of radiation-induced xerostomia. Available studies suggest that approximately half of patients will respond, but side effects can be problematic. The conclusions of the update are the same as the conclusions of the original review, since no new relevant studies have been published in the interim." @default.
- W2123807072 created "2016-06-24" @default.
- W2123807072 creator A5033780979 @default.
- W2123807072 creator A5086408188 @default.
- W2123807072 date "2015-10-05" @default.
- W2123807072 modified "2023-10-13" @default.
- W2123807072 title "Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy" @default.
- W2123807072 cites W1519068286 @default.
- W2123807072 cites W1682939406 @default.
- W2123807072 cites W1846716296 @default.
- W2123807072 cites W1918350968 @default.
- W2123807072 cites W1939190437 @default.
- W2123807072 cites W197843134 @default.
- W2123807072 cites W1978468215 @default.
- W2123807072 cites W1994410698 @default.
- W2123807072 cites W1995251111 @default.
- W2123807072 cites W2005436450 @default.
- W2123807072 cites W2006452350 @default.
- W2123807072 cites W2014660822 @default.
- W2123807072 cites W2018980281 @default.
- W2123807072 cites W2032387707 @default.
- W2123807072 cites W2033821613 @default.
- W2123807072 cites W2039520842 @default.
- W2123807072 cites W2042588685 @default.
- W2123807072 cites W2061017850 @default.
- W2123807072 cites W2062930475 @default.
- W2123807072 cites W2063020735 @default.
- W2123807072 cites W2063126695 @default.
- W2123807072 cites W2068627897 @default.
- W2123807072 cites W2083858338 @default.
- W2123807072 cites W2083930799 @default.
- W2123807072 cites W2090746824 @default.
- W2123807072 cites W2099973353 @default.
- W2123807072 cites W2128952013 @default.
- W2123807072 cites W2147570711 @default.
- W2123807072 cites W2147587535 @default.
- W2123807072 cites W2154612768 @default.
- W2123807072 cites W2167153589 @default.
- W2123807072 cites W2175528908 @default.
- W2123807072 cites W2337821609 @default.
- W2123807072 cites W2398887190 @default.
- W2123807072 cites W2505197231 @default.
- W2123807072 cites W67239065 @default.
- W2123807072 cites W2418557414 @default.
- W2123807072 doi "https://doi.org/10.1002/14651858.cd003782.pub3" @default.
- W2123807072 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6599847" @default.
- W2123807072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26436597" @default.
- W2123807072 hasPublicationYear "2015" @default.
- W2123807072 type Work @default.
- W2123807072 sameAs 2123807072 @default.
- W2123807072 citedByCount "34" @default.
- W2123807072 countsByYear W21238070722013 @default.
- W2123807072 countsByYear W21238070722014 @default.
- W2123807072 countsByYear W21238070722015 @default.
- W2123807072 countsByYear W21238070722016 @default.
- W2123807072 countsByYear W21238070722017 @default.
- W2123807072 countsByYear W21238070722018 @default.
- W2123807072 countsByYear W21238070722019 @default.
- W2123807072 countsByYear W21238070722020 @default.
- W2123807072 countsByYear W21238070722021 @default.
- W2123807072 countsByYear W21238070722022 @default.
- W2123807072 countsByYear W21238070722023 @default.
- W2123807072 crossrefType "journal-article" @default.
- W2123807072 hasAuthorship W2123807072A5033780979 @default.
- W2123807072 hasAuthorship W2123807072A5086408188 @default.
- W2123807072 hasBestOaLocation W21238070722 @default.
- W2123807072 hasConcept C118552586 @default.
- W2123807072 hasConcept C126322002 @default.
- W2123807072 hasConcept C17744445 @default.
- W2123807072 hasConcept C197934379 @default.
- W2123807072 hasConcept C199539241 @default.
- W2123807072 hasConcept C27415008 @default.
- W2123807072 hasConcept C2777204577 @default.
- W2123807072 hasConcept C2778186239 @default.
- W2123807072 hasConcept C2778375690 @default.
- W2123807072 hasConcept C2779473830 @default.
- W2123807072 hasConcept C2781145037 @default.
- W2123807072 hasConcept C509974204 @default.
- W2123807072 hasConcept C71924100 @default.
- W2123807072 hasConceptScore W2123807072C118552586 @default.
- W2123807072 hasConceptScore W2123807072C126322002 @default.
- W2123807072 hasConceptScore W2123807072C17744445 @default.
- W2123807072 hasConceptScore W2123807072C197934379 @default.
- W2123807072 hasConceptScore W2123807072C199539241 @default.
- W2123807072 hasConceptScore W2123807072C27415008 @default.
- W2123807072 hasConceptScore W2123807072C2777204577 @default.
- W2123807072 hasConceptScore W2123807072C2778186239 @default.
- W2123807072 hasConceptScore W2123807072C2778375690 @default.
- W2123807072 hasConceptScore W2123807072C2779473830 @default.
- W2123807072 hasConceptScore W2123807072C2781145037 @default.
- W2123807072 hasConceptScore W2123807072C509974204 @default.
- W2123807072 hasConceptScore W2123807072C71924100 @default.
- W2123807072 hasIssue "10" @default.
- W2123807072 hasLocation W21238070721 @default.
- W2123807072 hasLocation W21238070722 @default.
- W2123807072 hasLocation W21238070723 @default.
- W2123807072 hasLocation W21238070724 @default.
- W2123807072 hasOpenAccess W2123807072 @default.
- W2123807072 hasPrimaryLocation W21238070721 @default.
- W2123807072 hasRelatedWork W1999383655 @default.